Evidence-rated, plain-language breakdowns of adjunct and integrative approaches in oncology — things worth considering alongside standard treatment, not instead of it.
The CO.21 CHALLENGE Trial published in NEJM in 2025 was the first phase 3 RCT to show that exercise improves survival in cancer patients. What it means, why it took this long, and what patients and families can do with the information.
Read post →The research ecosystem doesn't fund what it can't patent. This post looks at the structural reasons why promising science never makes it to clinical conversation — and why that's not the same as the science being wrong.
Read post →What was dismissed as alternative medicine a decade ago is increasingly showing up in peer-reviewed literature and major cancer centres. What changed, what hasn't, and what it means for patients navigating the space.
Read post →When a family member is diagnosed, the first question is who to trust. This post explores the information gap that opens the moment treatment begins — and the difficulty of navigating it without a guide.
Read post →